WADA, world sport’s anti-doping body, will not appeal against the one-month doping sanction levied against tennis world No 2 Iga Swiatek. The Pole recorded a positive test for the banned substance trimetazidine (TMZ) in August.

WADA released its decision after Iga Swiatek sealed a victory against Eva Lys to reach the Australian Open quarterfinals.

The World Anti-Doping Agency will not appeal against the ban given to Poland's Iga Swiatek. The five-time major winner tested positive for heart medication trimetazidine (TMZ) in an out-of-competition sample in August 2024.

The World Anti-Doping Agency (WADA) said on Monday it would not lodge an appeal to the Court of Arbitration for Sport (CAS) in the case of Iga Swiatek after the former world number one tested positive for prohibited substance trimetazidine (TMZ).

World No. 2 and five-time Grand Slam champion Iga Swiatek opened up about her recent one-month doping ban for a positive drug test, describing it as the most challenging period of her tennis career. Speaking on the eve of the Australian Open, Swiatek shared that the ordeal was “pretty chaotic” and labeled it the “worst time” of her life.

Iga Swiatek, a self-described “control freak,” is taking new precautions — including holding on to extra samples of medicine she takes, in case they need to be tested at some point — after a doping case she describes as probably the worst time in her life.

Iga Swiatek expressed her satisfaction after the World Anti-Doping Agency (WADA) announced its decision not to appeal the doping ban imposed on the world No. 2. The Polish tennis star, who has maintained her innocence throughout the proceedings,

Iga Swiatek felt satisfaction and hoped for closure after the World Anti-Doping Agency (WADA) said on Monday that it would not appeal her case at sport's highest court. WADA's announcement came shortl

The findings for the world No.2 were released straight after her win over Eva Lys in the fourth round of the Australian Open.